Health Condition 1: M238- Other internal derangements of knee
Conditions
Interventions
Intervention1: Addition of butorphanol: The other two groups , group R1 will be having ropivacaine 0.2%,19ml with 1mg/ml of butorphanol and group R2 will be having ropivacaine0.2%, 19ml with 2mg/ml of
Sponsors
Swami Rama Himalayan University
Eligibility
Inclusion criteria
Inclusion criteria: 1- patient aged 18 to 60 years 2- ASA Grade 1 and 2 3- consent for regional anaesthesia
Exclusion criteria
Exclusion criteria: 1-ASA III and IV 2-Refusal or contraindication for regional anaesthesia 3-Known allergy to local anaesthesia 4-Bleeding disorder 5-Patient on anticoagulant medications 6-Infection at local site 7-Significant cardiac disease, renal failure, Asthma 8-Patient with psychiatric disorder or inability to operate PCA pump 9- Body mass index more than 30 kilogram per metre square of height
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of duration of analgesia detected by the first analgesia rescue dose and total analgesic consumptionTimepoint: first analgesia rescue dose and total analgesic consumption | — |
Secondary
| Measure | Time frame |
|---|---|
| The impact of single shot adductor canal blovk using ropivacaine and butorphanol on postoperative recoveryTimepoint: Patient outcome assessment , sedation , and the side effects that could occur in yhr 24 hour study period in patients undertaking tptal knee arhtroscopu | — |
Countries
India
Contacts
Public ContactMohit Kandari
Himalayan Institute of Medical Sciences, SRHU Dehradun
Outcome results
None listed